Tessier-Lavigne Marc's Form 4 filing
Denali Therapeutics Inc. (DNLI) · filed Dec 30, 2021
- Accession no.
- 0001714899-21-000117
- Filed
- Dec 30, 2021
- Trade date
- Oct 4-Dec 30, 2021
- Filing delay
- 87 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 16 non-derivative transactions. Open-market sales total $2.81M. It was filed 87 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tessier-Lavigne MarcCIK 0001437435 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | Common Stock | GGiftDisposed | −300,000 | $0.00F1 | $0 | 2,244,370 | Direct | |
| Oct 4, 2021 | Common Stock | GGiftAcquired | +100,000 | $0.00F1 | $0 | 100,000 | Indirect | |
| Dec 28, 2021 | Common Stock | SSaleDisposed | −3,732 | $44.37F4 | −$165,588.84 | 96,268 | Indirect | |
| Dec 29, 2021 | Common Stock | SSaleDisposed | −10,700 | $43.88F5 | −$469,516 | 85,568 | Indirect | |
| Dec 30, 2021 | Common Stock | SSaleDisposed | −3,343 | $45.13F6 | −$150,869.59 | 82,225 | Indirect | |
| Dec 30, 2021 | Common Stock | SSaleDisposed | −3,377 | $45.59F7 | −$153,957.43 | 78,848 | Indirect | |
| Oct 4, 2021 | Common Stock | GGiftAcquired | +100,000 | $0.00F1 | $0 | 100,000 | Indirect | |
| Dec 28, 2021 | Common Stock | SSaleDisposed | −3,602 | $44.38F9 | −$159,856.76 | 96,398 | Indirect | |
| Dec 29, 2021 | Common Stock | SSaleDisposed | −10,700 | $43.87F10 | −$469,409 | 85,698 | Indirect | |
| Dec 30, 2021 | Common Stock | SSaleDisposed | −5,625 | $45.31F11 | −$254,868.75 | 80,073 | Indirect | |
| Dec 30, 2021 | Common Stock | SSaleDisposed | −900 | $45.71F12 | −$41,139 | 79,173 | Indirect | |
| Oct 4, 2021 | Common Stock | GGiftAcquired | +100,000 | $0.00F1 | $0 | 100,000 | Indirect | |
| Dec 28, 2021 | Common Stock | SSaleDisposed | −3,646 | $44.37F14 | −$161,773.02 | 96,354 | Indirect | |
| Dec 29, 2021 | Common Stock | SSaleDisposed | −10,704 | $43.88F15 | −$469,691.52 | 85,650 | Indirect | |
| Dec 30, 2021 | Common Stock | SSaleDisposed | −6,002 | $45.31F16 | −$271,950.62 | 79,648 | Indirect | |
| Dec 30, 2021 | Common Stock | SSaleDisposed | −800 | $45.72F17 | −$36,576 | 78,848 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction involved a gift of securities by the Reporting Person. Disposition price is not applicable as this transaction was a bona fide gift.
Referenced by the price of 4 transactions in Table I.
- F4
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.19 to $44.74 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $43.50 to $44.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.42 to $45.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $45.42 to $45.81 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.19 to $44.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $43.51 to $44.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F11
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.65 to $45.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F12
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $45.66 to $45.77 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F14
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.18 to $44.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F15
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $43.50 to $44.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F16
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.65 to $45.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F17
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $45.67 to $45.80 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.